Best practice Minebea Intec’s products support the creation of a vaccine against Corona The Chinese biotech company CanSino was one of the first companies allowed to conduct clinical trials with a possible vaccine against the coronavirus. Minebea Intec supported this project with precise weighing equipment. Key facts For the research and development of vaccines, every detail has to be critically controlled to ensure the resulting products are exactly what is needed. For the accurate monitoring and controlling of the weight, C anSino chose Minebea Intec to provide the right solutions. Three load cells PR 6212 were installed under a bioreactor to monitor the weighing data of the vaccine raw-form in real time. An IF platform scale was used for the manual formulation of the final vaccine. Precise weighing results in real time Compact design for easy installation of load cell Load cells PR 6212/500 kg C1 Cable junction box PR 6130/65S Transmitter PR 5211/10 IFS4-300II-I-T16 Customer Founded in Tianjin, China 2009, CanSino Biologics Inc. is an innovative biopharmaceutical company for human use vaccine R&D, manufacturing and commercialization. It has an R&D centre of approximately 120,000 square-feet as well as a 380,000 square-feet commercial manufacturing campus. Customer benefits Low profile of IF scale allows fast and efficient loading Maximum corrosion resistance of load cell

Project goal and implementation The dedication of CanSino is to find the best solutions for the prevention of diseases, such as the coronavirus. To conduct their research, the company has been relying on weighing solutions from Minebea Intec for many projects. In 2017, when CanSino received the NDA approval to produce the ad5-EBOV vaccine as a solution against the ebola virus, they needed a weighing solution to formulate the final vaccine product and opted for an IF scale, which they also used in their search for a vaccine against corona. The creation of a vaccine, based on the adenovirus-based...